Berkshire Hills Bancorp (BHLB) 27.45 $BHLB Ray Bourque

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Berkshire Hills Bancorp (BHLB) 27.45 $BHLB

Ray Bourque and Milan Lucic Join Berkshire Bank as Spokespersons
PR Newswire - Thu Mar 12, 3:17PM CDT
Berkshire Hills Bancorp, Inc. (NYSE: BHLB), parent of Berkshire Bank, America's Most Exciting Bank®, today announced that hockey legend Ray Bourque and Boston Bruins left wing Milan Lucic will serve as spokespersons for the Bank, including endorsement of its financial services and products. The partnership with the players comes as the Bank continues to grow its presence across New England and New York, and evolve its offerings to meet customers' changing needs.
BHLB: 27.45 (+0.51)

Hampden Bancorp, Inc. Stockholders Approve Merger
GlobeNewswire - Thu Mar 12, 3:05PM CDT
Hampden Bancorp, Inc. (Nasdaq:HBNK) today announced that its stockholders have voted to approve the previously announced merger of Hampden with Berkshire Hills Bancorp, Inc. The companies expect to complete the merger in April 2015, although there can be no assurance that the closing will occur then. Consummation of the merger is subject to approval by state and federal regulatory agencies.
HBNK: 21.90 (+0.44), BHLB: 27.45 (+0.51)

Why You Shouldn't Bet Against Berkshire Hills (BHLB) Stock - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri Feb 13, 7:41AM CST
One stock that might be an intriguing choice for investors right now is Berkshire Hills as this security in the financial savings and loan industry space is seeing solid earnings estimate revision activity, and is in great company from a Zacks Industry Rank perspective.
BHLB: 27.45 (+0.51)

Berkshire Hills Bancorp's (BHLB) CEO Mike Daly on Q4 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Tue Jan 27, 1:15PM CST

BHLB: 27.45 (+0.51)

Berkshire Hills beats 4Q profit forecasts
Automated Insights - Mon Jan 26, 3:45PM CST
PITTSFIELD, Mass. (AP) _ Berkshire Hills Bancorp Inc. (BHLB) on Monday reported fourth-quarter net income of $11.4 million.
BHLB: 27.45 (+0.51)

Berkshire Hills Bancorp beats by $0.01, beats on revenue
Seeking Alpha - at Seeking Alpha - Mon Jan 26, 3:22PM CST

BHLB: 27.45 (+0.51)

Berkshire Hills Reports 20% Increase in Fourth Quarter Core EPS; Dividend Increased; Annual Meeting Date Set
PR Newswire - Mon Jan 26, 3:15PM CST
Berkshire Hills Bancorp, Inc. (NYSE: BHLB) reported a 20% increase in fourth quarter core earnings per share to $0.48 in 2014 compared to $0.40 in 2013. Earnings growth was driven by a 17% increase in core revenue as the Company expanded operations in its footprint. Fourth quarter GAAP EPS increased by 10% to $0.46 as earnings in both years were impacted by non-core charges related primarily to growth and restructuring.
BHLB: 27.45 (+0.51)

Berkshire - Hampden Merger: A Story Of Activism
Maudes Capital - at Seeking Alpha - Fri Jan 23, 8:23AM CST

HBNK: 21.90 (+0.44), BHLB: 27.45 (+0.51)

Berkshire Hills Fourth Quarter 2014 Earnings Release and Conference Call Dates
PR Newswire - Tue Jan 06, 8:15AM CST
Berkshire Hills Bancorp, Inc. (NYSE: BHLB) will issue its fourth quarter earnings release after the market closes on Monday, January 26, 2015.
BHLB: 27.45 (+0.51)

Is Berkshire Hills (BHLB) Stock a Solid Choice Right Now? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Dec 02, 7:48AM CST
Berkshire Hills might be an intriguing choice for investors as it is seeing solid earnings estimate revision activity and is in great company from a Zacks Industry Rank perspective
BHLB: 27.45 (+0.51)

HBNK INVESTOR ALERT: The Law Offices of Vincent Wong Announces Investigation of the Board of Directors of Hampden Bancorp, Inc. in Connection With the Fairness of the Sale of the Company to Berkshire Hills Bancorp - HBNK
PR Newswire - Mon Dec 01, 3:49PM CST
The Law Offices of Vincent Wong are investigating potential claims against the Board of Directors of Hampden Bancorp, Inc. (Nasdaq: HBNK) ("Hampden" in connection with the sale of the Company to Berkshire Hills Bancorp (NYSE: BHLB) ("Berkshire".
HBNK: 21.90 (+0.44), BHLB: 27.45 (+0.51)

SHAREHOLDER ALERT: Brodsky & Smith, LLC Announces Investigation of Hampden Bancorp, Inc. in Connection with the Sale of the Company
Business Wire - Wed Nov 26, 1:09PM CST
Law office of Brodsky & Smith, LLC announces that it is investigating potential claims against the Board of Directors of Hampden Bancorp, Inc. ("Hampden" or the "Company" (Nasdaq: HBNK) relating to the proposed acquisition by Berkshire Hills Bancorp, Inc. ("Berkshire".
HBNK: 21.90 (+0.44), BHLB: 27.45 (+0.51)

HBNK INVESTOR ALERT: The Law Offices of Vincent Wong Announces Investigation of the Board of Directors of Hampden Bancorp, Inc. in Connection With the Fairness of the Sale of the Company to Berkshire Hills Bancorp
Business Wire - Wed Nov 12, 2:07PM CST
The Law Offices of Vincent Wong are investigating potential claims against the Board of Directors of Hampden Bancorp, Inc. (Nasdaq:HBNK) ("Hampden" in connection with the sale of the Company to Berkshire Hills Bancorp (NYSE: BHLB) ("Berkshire".
HBNK: 21.90 (+0.44), BHLB: 27.45 (+0.51)

Berkshire Hills to Present at the Southwest IDEAS Investor Conference on November 20th in Dallas
PR Newswire - Mon Nov 10, 4:30PM CST
Berkshire Hills Bancorp, Inc. (NYSE: BHLB) today announced that Josephine Iannelli, Chief Financial Officer, will present at the Southwest IDEAS Investor Conference on Thursday November 20, 2014 at the Marriott - Quorum Hotel in Addison, Texas. Berkshire's presentation is scheduled to begin at 9:40am EST. The presentation will be webcast live and may be accessed at the conference website, www.IDEASConferences.com, or in the investor relations section of the company's website: ir.berkshirebank.com.
BHLB: 27.45 (+0.51)

Merger Arbitrage Mondays - November 10, 2014
Asif Suria - Seeking Alpha - Mon Nov 10, 11:24AM CST
Merger Activity increased last week with six new mergers announced and one deal closing. You can find all the active deals listed below in our Merger Arbitrage Tool that automatically updates itself during market hours. Deal Statistics: ...
ESYS: 17.46 (+0.01), HBNK: 21.90 (+0.44), LNN: 82.19 (-0.44), BHLB: 27.45 (+0.51), SAPE: 24.98 (-0.02), XWES: 5.46 (-0.03), ENOC: 10.75 (-0.21), LH: 126.80 (+0.54), STL: 13.65 (+0.15), HVB: 26.03 (+0.21), BAGL: 20.23 (-0.01), CVD: 106.42 (-0.71)

HBNK SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces Investigation of the Board of Directors of Hampden Bancorp, Inc. Concerning the Fairness of the Sale of the Company to Berkshire Hills Bancorp -- HBNK
Business Wire - Mon Nov 10, 10:35AM CST
Levi & Korsinsky is investigating the Board of Directors of Hampden Bancorp, Inc. ("Hampden" or "the Company" (Nasdaq:HBNK) for possible breaches of fiduciary duty and other violations of state law in connection with the sale of the Company to Berkshire Hills Bancorp ("Berkshire" (NYSE:BHLB).
HBNK: 21.90 (+0.44), BHLB: 27.45 (+0.51)

HAMPDEN BANCORP, INC. SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Announces the Investigation of Hampden Bancorp, Inc. Over the Proposed Sale of the Company to Berkshire Hills Bancorp, Inc. - HBNK
PR Newswire - Fri Nov 07, 7:30PM CST
Juan E. Monteverde, a partner at Faruqi & Faruqi, LLP, a leading national securities firm headquartered in New York City, is investigating the Board of Directors of Hampden Bancorp, Inc. ("Hampden" or the "Company" (Nasdaq: HBNK) for potential breaches of fiduciary duties in connection with the sale of the Company to Berkshire Hills Bancorp, Inc. in an all-stock transaction for approximately $109 million. The Company's stockholders will only receive 0.81 shares for each share of Hampden common stock they own.
HBNK: 21.90 (+0.44), BHLB: 27.45 (+0.51)

SHAREHOLDER ALERT: Brodsky & Smith, LLC Announces Investigation of Hampden Bancorp, Inc. in Connection with the Sale of the Company -HBNK
PR Newswire - Fri Nov 07, 6:33PM CST
Law office of Brodsky & Smith, LLC announces that it is investigating potential claims against the Board of Directors of Hampden Bancorp, Inc. ("Hampden" or the ("Company" (Nasdaq: HBNK) relating to the proposed acquisition by Berkshire Hills Bancorp, Inc. ("Berkshire".
HBNK: 21.90 (+0.44), BHLB: 27.45 (+0.51)

INVESTOR ALERT: Levi & Korsinsky, LLP Launches Investigation of the Board of Directors of Hampden Bancorp, Inc. Regarding the Fairness of the Sale of the Company to Berkshire Hills Bancorp -- HBNK
PR Newswire - Wed Nov 05, 11:48AM CST
Levi & Korsinsky is investigating the Board of Directors of Hampden Bancorp, Inc. ("Hampden" or "the Company" (Nasdaq: HBNK) for possible breaches of fiduciary duty and other violations of state law in connection with the sale of the Company to Berkshire Hills Bancorp ("Berkshire" (NYSE: BHLB).
HBNK: 21.90 (+0.44), BHLB: 27.45 (+0.51)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

WHO and RCSI Bahrain Join Forces on Health Initiatives

Updated Category News Views 454

Forging a Healthier Pathway In a world where healthcare challenges rise faster than my blood pressure during a stock market crash, the World Health Organization (WHO) and the Royal College of Surgeons in Ireland (RCSI) – Medical University of Bahrain have inked a deal to tackle these issues head-on. The memorandum of understanding (MoU) signed on November 15, 2026,...

Continue Reading
Kayla Harrison Dominates UFC 334, Earns Big Win

Updated Category News Views 59

Kicking off UFC 334 with a bang, Kayla Harrison didn't just step into the Octagon—she bulldozed her way through Amanda Nunes to retain her Women's Bantamweight Championship. This showdown didn't just electrify New York's Madison Square Garden, it shook the entire MMA landscape. Harrison, the face of Monster Energy's athlete roster, wasn't content with just defending her...

Continue Reading
JOYEE N01 Debuts Globally with First 2,000 Deliveries

Updated Category News Views 387

JOYYE N01 Breaks into the Global Market Now, here we go, folks—a Chinese car with ambitions bigger than the Sahara. On October 28, the JOYEE N01 rolled off the assembly line and into the international scene with a lot of fanfare at FAW's Yancheng Branch. Mark my words, this isn't just another model trying to strut into the global auto arena. This event delivered the...

Continue Reading
Berry Street Integrates AI with What Matters: Human Touch

Updated Category News Views 283

Health Meets AI at Berry Street In recent waves of news, Berry Street has decided to toss MyScribe, a standalone AI service, into its shopping cart and welcomed its brainwave behind it, Dr. Wasif Bokhari, into their corridors. Yep, they’ve snagged both the tech and the mind! It's the kind of move that makes you stop midway through your diner coffee. Here’s Berry...

Continue Reading
Innovent's Big Leap: Targeting European Lung Cancer Market

Updated Category News Views 162

Innovent's Regulatory Milestone in Europe They say every underdog has its day, and for Innovent Biologics, that time just might be now. Receiving a positive opinion from the Committee for Medicinal Products for Human Use (CHMP) is no small potatoes. Especially when we're talking lung cancer—a notorious heavyweight in the cancer world. The Finer Details of Zybrivo’s...

Continue Reading
InstaHeat 35K: FOGATTI Offers Upgraded RV Furnace Control

Updated Category News Views 493

Winter RV Trips Just Got Cozier There's nothing quite like hitting the open road in an RV during the winter months. But let's face it, nobody wants to return to a cabin that's as frigid as the great outdoors. Here's where FOGATTI steps up its game with the InstaHeat Ultra 35K RV Furnace. They’ve tinkered with the thermostat to iron out more precise control, just in time...

Continue Reading
Midea's R290 Tech: Real Green Cooling Revolution?

Updated Category News Views 66

A Fresh Breeze in Sustainable Cooling In the middle of Kigali’s innovation oasis, Midea RAC stood out at MOP38, the 38th Meeting of the Parties to the Montreal Protocol, flexing its sustainable tech muscles. We're talking about their R290 air conditioning technology—a natural refrigerant with zero ozone footprint and a global warming potential of a mere three. This is...

Continue Reading
Ampace Focuses on Battery Safety Standards at RE+ 2026

Updated Category News Views 77

Battery Safety Takes Center Stage No mystery here: the safety of our beloved lithium-ion batteries is crucial, especially as AI data centers sprout like weeds. At RE+ 2026, Ampace is putting its chips on the table by spotlighting this hot topic. Dr. Drew Feng, their Chief Safety Officer, is set to reveal the big guns: findings from the PU100 large-scale fire test. Mark...

Continue Reading
Novo's CagriSema Trials Show Promising Weight Loss

Updated Category News Views 421

Decoding CagriSema's Promise Let me tell you, when those corporate folks from Novo Nordisk announce something big like their investigational drug CagriSema at ObesityWeek® 2026, it’s time to take notice. This isn’t just your average press release about some new weight loss fad. We’re talking about a phase 3 REDEFINE 1 trial that opens up a treasure chest of data...

Continue Reading
Portillo's Faces Class Action: Investor Losses at Stake

Updated Category News Views 304

Investor Tensions Rise as Portillo's Inc. Lawsuit Unfolds Investment ain't all sunshine and rainbows, and if you've been holding Portillo's Inc. (NASDAQ: PTLO) stocks between September 19, 2023, and May 4, 2026, you might find yourself caught in a storm front. We're talking shareholder class action lawsuit, folks, thanks to some allegedly misguided management moves. This...

Continue Reading

Top 5 Most Recently Viewed Articles

Ventas to Showcase Investment Strategy at Real Estate Conference

Updated Category News Views 44

Ventas Engages Investors at Upcoming Conference Ventas, Inc. (NYSE: VTR) is gearing up to take part in significant investor meetings at the BofA Securities 2024 Global Real Estate Conference. This event presents a valuable chance for the company to connect with investors and share insights about its strategic direction and business model. Event Details and Participation...

Continue Reading
BioLineRx Explores Synergy in Ovarian Cancer Treatment

Updated Category News Views 151

New Hope on the Ovarian Cancer Front Every so often, something comes along and makes you stop and think—could this be the game-changer in the making? Well, what BioLineRx Ltd. (NASDAQ: BLRX) and Hemispherian AS just dropped at the ESMO 2026 feels a bit like that silver lining for folks fighting the uphill battle against homologous recombination (HR)-proficient ovarian...

Continue Reading
Analyst Ratings Show Confidence in Datadog and Others

Updated Category News Views 80

Recent Upgrades by Top Analysts Leading financial analysts from Wall Street have adjusted their outlooks on several prominent companies, reflecting a more optimistic market sentiment. Upgrades often signify increased confidence in a company's performance and present potential investment opportunities for savvy investors. Here, we delve into some of the standout upgrades...

Continue Reading
Unpacking the Increased Short Interest in Ventas (NYSE: VTR)

Updated Category News Views 77

Understanding Ventas's Short Interest Surge Ventas recently recorded an uptick in its short percent of float, which now stands at 25.59% since the last report. This notable development means that 9.80 million shares are currently sold short, translating to 3.19% of all regular shares available for trading. Given the trading volume, it would take traders approximately 3.33...

Continue Reading
Precigen's PAPZIMEOS: 7-Year Exclusivity & Long-Term Success

Updated Category News Views 54

Precigen's Game-Changer: PAPZIMEOS Secures Seven-Year Exclusivity Here's how you carve out a solid niche in the biotech world: deliver some killer results and snag yourself seven years in the driver’s seat. That's exactly what Precigen (NASDAQ: PGEN) has done with their PAPZIMEOS therapy, which got the stamp of approval from the FDA as the first exclusive treatment for...

Continue Reading